|
 Connie
R. Jimenez, Ph.D. is a biologist with an interest in
sub-cellular organelles in relation to function in
health and disease. She is head of the recently
established OncoProteomics Laboratory of the Cancer
Center Amsterdam at the VU Medical Center. In 1993,
during her graduate studies at the Vrije Universiteit in
Amsterdam, she pioneered the use of MALDI-TOF mass
spectrometry for differential display of neuropeptides
in single cells and, in 1997, for semi-quantitative
neuropeptide profiling directly in tissue homogenates.
Since her post-doc at UCSF (San Francisco, USA) in
1997-1999, she has used proteomics as a tool to solve a
range of neuroscience-related questions and more
recently for cancer research and biomarker discovery.
In 2000, Dr. Jimenez initiated and is still coordinating
the Netherlands Proteomics Platform. Dr. Jimenez
participates in several international networks (European
Proteomics Association, biomarker discovery committee of
the HUPO-Brain project, EU kp6 consortia cNeuPRO and
Angiotargeting and the International Cancer Biomarker
Consortium) and she is editorial board member of the new
Journal of Proteomics.
|
